BAFNA PHARMACEUTICALS LIMITED

Highlights Bafna Pharmaceuticals Limited Bombay S.E.

Equities

BAFNAPH

INE878I01022

Market Closed - Bombay S.E. Other stock markets 06:00:54 2024-07-12 am EDT			5-day change	1st Jan Change
91.08 ^INR	+1.95%		+1.18%	-2.92%

Jun. 29	Bafna Pharmaceuticals Limited Announces Temporary Disruption of Operations At Manufacturing Facility Situated At Grantlyon, Chennai	CI
May. 29	Bafna Pharmaceuticals Limited Approves the Appointment of A. Mohanachandran as Company Secretary and Compliance Officer	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 29	CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 29	CI
Bafna Pharmaceuticals Limited Announces the Inauguration of New Quality Control Laboratory	Apr. 26	CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-27	CI
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer